Strategies for silencing human disease using RNA interference
Top Cited Papers
- 1 March 2007
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Genetics
- Vol. 8 (3), 173-184
- https://doi.org/10.1038/nrg2006
Abstract
Since the first description of RNA interference (RNAi) in animals less than a decade ago, there has been rapid progress towards its use as a therapeutic modality against human diseases. Advances in our understanding of the mechanisms of RNAi and studies of RNAi in vivo indicate that RNAi-based therapies might soon provide a powerful new arsenal against pathogens and diseases for which treatment options are currently limited. Recent findings have highlighted both promise and challenges in using RNAi for therapeutic applications. Design and delivery strategies for RNAi effector molecules must be carefully considered to address safety concerns and to ensure effective, successful treatment of human diseases.Keywords
This publication has 92 references indexed in Scilit:
- Optimization and Functional Effects of Stable Short Hairpin RNA Expression in Primary Human Lymphocytes via Lentiviral VectorsMolecular Therapy, 2006
- Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathwaysNature, 2006
- Second-generation shRNA libraries covering the mouse and human genomesNature Genetics, 2005
- TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencingNature, 2005
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005
- Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacyNature Biotechnology, 2004
- The Microprocessor complex mediates the genesis of microRNAsNature, 2004
- Mechanisms of gene silencing by double-stranded RNANature, 2004
- Unlocking the potential of the human genome with RNA interferenceNature, 2004
- Structural basis for overhang-specific small interfering RNA recognition by the PAZ domainNature, 2004